Skip to content

A randomized controlled clinical trial of simultaneous repair of alveolar cleft in secondary deformities of cleft lip

A randomized controlled clinical trial of simultaneous repair of alveolar cleft in secondary deformities of cleft lip

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054373
Enrollment
Unknown
Registered
2021-12-16
Start date
2021-12-16
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cleft lip and palate

Interventions

Experimental group1:Simultaneous repair of alveolar cleft with autogenous iliac bone graft
Experimental group2:Simultaneous repair of alveolar cleft with TCP
Control group:Repair of secondary cleft lip deformity

Sponsors

Plastic Surgery Hospital of Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 25 Years

Inclusion criteria

Inclusion criteria: 1. Aged 16 to 25 years; 2. Patients with unilateral cleft lip or cleft lip and palate diagnosed at birth, who have undergone cleft lip repair surgery before; 3. There is obvious alveolar ridge fracture in preoperative diagnosis; the volume of bone defect is in the range of 1-3cm^3; 4. No alveolar ridge repair or gingival periosteoplasty (GPP) was performed before this alveolar ridge repair; 5. No orthodontic treatment before this alveolar ridge repair surgery; 6. Normal communication skills; 7. The admission examination is basically normal; 8. Patients or guardians agree to participate in this experiment and sign the informed consent; 9. Patients who meet the above conditions within 48 months of the start of the project.

Exclusion criteria

Exclusion criteria: 1. Combined giant palatal fistula; 2. Those with severe impairment of vital organ functions such as heart, lung, brain, kidney, and hematopoietic function; 3. Patients with a history or related examination findings of other bone metabolic diseases that may affect bone healing (such as osteoporosis, osteomalacia, etc.); 4. Active period of infectious disease; 5. Patients with poor systemic nutritional status; 6. The bone defect is larger than 3cm^3, and the continuous damage requires a large amount of transplanted bone for the bone defect; 7. Patients with allergic constitution or allergic to disease treatment-related materials, reagents and drugs (ß-TCP, titanium nails); 8. Patients with alcohol or addictive drug dependence; 9. Those who are participating in other clinical trials and have not reached the end point.

Design outcomes

Primary

MeasureTime frame
Osteogenesis rate;Lip and nose symmetry;

Secondary

MeasureTime frame
Infection rate;

Countries

China

Contacts

Public ContactWang Yongqian

Plastic Surgery Hospital of Peking Union Medical College

surgeonfrank@163.com+86 13366682856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026